Document is current
Any future updates will be listed below
-
Authors
Ozawa, Nanaka
Takeyama, Erina
Sakai, Honoka
Katayama, Ayaka
Onishi, Mai
Kizawa, Rika
Matsunaga, Yuki
Nozawa, Kazuki
Umezaki, Nodoka
Mitsueda, Reiko
Tanabe, Keiko
Sekine, Chikako
Golshan, Mehra
Rakha, Emad A.
Horiguchi, Jun
Kurozumi, Sasagu
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (16K19906)
- License Information
-
More Information
Article History
Received: 6 March 2025
Accepted: 18 August 2025
First Online: 12 September 2025
Disclosure
: Kazuki Nozawa has received lecture fees from Eli Lily, Daiichi Sankyo, Chugai Pharmaceuticals, and Pfizer. Sasagu Kurozumi has received honoraria from Kyowa Kirin Co., Ltd, Daiichi Sankyo Co. Ltd, Taiho Pharmaceutical Co., Ltd, Eli Lilly and Company, MSD K.K., AstraZeneca K.K., Chugai Pharmaceutical, Ltd, Dinow Inc., Eisai Co., Ltd, Takeda Pharmaceutical Co., Ltd, and Pfizer Japan Inc. Nanaka Ozawa, Erina Takeyama, Honoka Sakai, Ayaka Katayama, Mai Onishi, Rika Kizawa, Yuki Matsunaga Nodoka Umezaki, Reiko Mitsueda, Keiko Tanabe, Chikako Sekine, Mehra Golshan, Emad A. Rakha, and Jun Horiguchi have no conflicts of interest to declare that may be relevant to the contents of this review.
